| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f6618ffa97d621cdfe9437fd02fcb7a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
| filingDate |
2014-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3933204b6393530d24cc963f2ebe8ee0 |
| publicationDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015026494-A2 |
| titleOfInvention |
Methods for treating tissue fibrosis |
| abstract |
The present invention includes methods for reducing tissue damage in patients undergoing radiation treatment or with idiopathic pulmonary fibrosis or scleroderma by inhibiting PAI-1 activity in the tissue with a truncated PAI-1 agent, rPAI-1 23 . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11219669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071772-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3556395-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017101873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110121358-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210910-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018107693-A1 |
| priorityDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |